USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Aug 10, 2022 | Jun 2022 | - | - | $-0.40 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Aug 10, 2022 | Jun 2022 | - | - | $0.00 |
Alx Oncology's next earnings date is Wednesday, Aug 10, 2022 for the fiscal quarter ending Jun 2022.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 6 | $-2.55 | $-3.25 | $-2.21 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2022 | 1 / 3 | $-2.37 | $-2.34 | $-2.25 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 5 | $520.00K | $0.00 | $2.60M |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| May 16, 2022 | Mar 2022 | $-0.71 | - | - |
| Feb 28, 2022 | Dec 2021 | $-0.62 | $-0.70 | -12.90% |
| Nov 11, 2021 | Sep 2021 | $-0.51 | $-0.61 | -19.33% |
| Aug 12, 2021 | Jun 2021 | $-0.46 | $-0.40 | 13.06% |
| May 17, 2021 | Mar 2021 | $-0.44 | $-0.35 | 19.63% |
| Mar 18, 2021 | Dec 2020 | $-0.35 | $-0.50 | -44.22% |
| Nov 12, 2020 | Sep 2020 | $-0.37 | $-0.29 | 21.65% |
| Aug 27, 2020 | Jun 2020 | $-0.32 | $-4.41 | -1278.13% |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Feb 28, 2022 | Dec 2021 | $-1.88 | $-2.06 | - |
| Mar 18, 2021 | Dec 2020 | $-1.88 | $-5.20 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| May 16, 2022 | Mar 2022 | $0.00 | - | - |
| Feb 28, 2022 | Dec 2021 | $0.00 | $0.00 | - |
| Nov 11, 2021 | Sep 2021 | $0.00 | $0.00 | - |
| Aug 12, 2021 | Jun 2021 | $0.00 | $0.00 | - |
| May 17, 2021 | Mar 2021 | $160.00K | $0.00 | - |
| Mar 18, 2021 | Dec 2020 | $0.00 | $1.18 | - |
| Nov 12, 2020 | Sep 2020 | $570.00K | $0.00 | - |
| Aug 27, 2020 | Jun 2020 | $750.00K | $527.00K | 0.70% |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Feb 28, 2022 | Dec 2021 | $0.00 | $0.00 | - |
| Mar 18, 2021 | Dec 2020 | $1.18M | $1.18M | 0.00% |
ALXO's next earnings date is Wednesday, Aug 10, 2022 for the fiscal quarter ending Jun 30, 2022.
Alx Oncology's previous earnings date was May 16, 2022 for its fiscal quarter ended Mar 31, 2022.
Alx Oncology's previous annual earnings date was Feb 28, 2022 for its fiscal year ended Dec 31, 2021.
ALXO's earnings per share (EPS) was $-2.06, missing the consensus analysts forecast of $-1.88 by 9.57% , and higher than the previous year's EPS (Dec 2020) by -60.38%.
Revenues were $0.00.
The company reported a net income of $-83.50M.
Alx Oncology reported a free cash flow of $-68.77M for its fiscal year, compared to $-38.32M a year ago.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
